Literature DB >> 20858552

Visfatin-induced lipid raft redox signaling platforms and dysfunction in glomerular endothelial cells.

Krishna M Boini1, Chun Zhang, Min Xia, Wei-Qing Han, Christopher Brimson, Justin L Poklis, Pin-Lan Li.   

Abstract

Adipokines have been reported to contribute to glomerular injury during obesity or diabetes mellitus. However, the mechanisms mediating the actions of various adipokines on the kidney remained elusive. The present study was performed to determine whether acid sphingomyelinase (ASM)-ceramide associated lipid raft (LR) clustering is involved in local oxidative stress in glomerular endothelial cells (GECs) induced by adipokines such as visfatin and adiponectin. Using confocal microscopy, visfatin but not adiponectin was found to increase LRs clustering in the membrane of GECs in a dose and time dependent manner. Upon visfatin stimulation ASMase activity was increased, and an aggregation of ASMase product, ceramide and NADPH oxidase subunits, gp91(phox) and p47(phox) was observed in the LR clusters, forming a LR redox signaling platform. The formation of this signaling platform was blocked by prior treatment with LR disruptor filipin, ASMase inhibitor amitriptyline, ASMase siRNA, gp91(phox) siRNA and adiponectin. Corresponding to LR clustering and aggregation of NADPH subunits, superoxide (O(2)(-)) production was significantly increased (2.7 folds) upon visfatin stimulation, as measured by electron spin resonance (ESR) spectrometry. Functionally, visfatin significantly increased the permeability of GEC layer in culture and disrupted microtubular networks, which were blocked by inhibition of LR redox signaling platform formation. In conclusion, the injurious effect of visfatin, but not adiponectin on the glomerular endothelium is associated with the formation of LR redox signaling platforms via LR clustering, which produces local oxidative stress resulting in the disruption of microtubular networks in GECs and increases the glomerular permeability. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20858552      PMCID: PMC2963068          DOI: 10.1016/j.bbalip.2010.09.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  63 in total

Review 1.  Role of small GTPases in endothelial cytoskeletal dynamics and the shear stress response.

Authors:  Eleni Tzima
Journal:  Circ Res       Date:  2006-02-03       Impact factor: 17.367

2.  Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease.

Authors:  Carmine Zoccali; Francesca Mallamaci; Giovanni Tripepi; Francesco A Benedetto; Sebastiano Cutrupi; Saverio Parlongo; Lorenzo S Malatino; Graziella Bonanno; Giuseppe Seminara; Francesco Rapisarda; Pasquale Fatuzzo; Michele Buemi; Giacomo Nicocia; Sachiyo Tanaka; Noriyuki Ouchi; Shinji Kihara; Tohru Funahashi; Yuji Matsuzawa
Journal:  J Am Soc Nephrol       Date:  2002-01       Impact factor: 10.121

3.  Spatially varying regularization based on spectrally resolved fluorescence emission in fluorescence molecular tomography.

Authors:  Johan Axelsson; Jenny Svensson; Stefan Andersson-Engels
Journal:  Opt Express       Date:  2007-10-17       Impact factor: 3.894

Review 4.  Regulation of death receptor signaling and apoptosis by ceramide.

Authors:  Erich Gulbins
Journal:  Pharmacol Res       Date:  2003-05       Impact factor: 7.658

5.  Adiponectin and renal function, and implication as a risk of cardiovascular disease.

Authors:  Yoshio Iwashima; Takeshi Horio; Masahiro Kumada; Yoshihiko Suzuki; Shinji Kihara; Hiromi Rakugi; Yuhei Kawano; Tohru Funahashi; Toshio Ogihara
Journal:  Am J Cardiol       Date:  2006-10-18       Impact factor: 2.778

6.  Adipokines in periaortic and epicardial adipose tissue: differential expression and relation to atherosclerosis.

Authors:  Sofia G Spiroglou; Christos G Kostopoulos; John N Varakis; Helen H Papadaki
Journal:  J Atheroscler Thromb       Date:  2010-02-10       Impact factor: 4.928

Review 7.  The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals.

Authors:  Javier R Revollo; Andrew A Grimm; Shin-ichiro Imai
Journal:  Curr Opin Gastroenterol       Date:  2007-03       Impact factor: 3.287

8.  Cigarette smoke metal-catalyzed protein oxidation leads to vascular endothelial cell contraction by depolymerization of microtubules.

Authors:  David Bernhard; Adam Csordas; Blair Henderson; Andrea Rossmann; Michaela Kind; Georg Wick
Journal:  FASEB J       Date:  2005-07       Impact factor: 5.191

9.  Target validation for genomics using peptide-specific phage antibodies: a study of five gene products overexpressed in colorectal cancer.

Authors:  Judy R Van Beijnum; Peter T M Moerkerk; Andrea J Gerbers; Adriaan P De Bruïne; Jan-Willem Arends; Hennie R Hoogenboom; Simon E Hufton
Journal:  Int J Cancer       Date:  2002-09-10       Impact factor: 7.396

10.  Critical role of lipid raft redox signaling platforms in endostatin-induced coronary endothelial dysfunction.

Authors:  Si Jin; Yang Zhang; Fan Yi; Pin-Lan Li
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-12-27       Impact factor: 8.311

View more
  30 in total

Review 1.  Annexins as organizers of cholesterol- and sphingomyelin-enriched membrane microdomains in Niemann-Pick type C disease.

Authors:  Magdalena Domon; Mehmet Nail Nasir; Gladys Matar; Slawomir Pikula; Françoise Besson; Joanna Bandorowicz-Pikula
Journal:  Cell Mol Life Sci       Date:  2011-12-13       Impact factor: 9.261

2.  Endothelial NLRP3 inflammasome activation and enhanced neointima formation in mice by adipokine visfatin.

Authors:  Min Xia; Krishna M Boini; Justine M Abais; Ming Xu; Yang Zhang; Pin-Lan Li
Journal:  Am J Pathol       Date:  2014-03-13       Impact factor: 4.307

3.  Activation of inflammasomes in podocyte injury of mice on the high fat diet: Effects of ASC gene deletion and silencing.

Authors:  Krishna M Boini; Min Xia; Justin M Abais; Guangbi Li; Ashley L Pitzer; Todd W B Gehr; Yang Zhang; Pin-Lan Li
Journal:  Biochim Biophys Acta       Date:  2014-02-05

4.  Lipid rafts are required for effective renal D1 dopamine receptor function.

Authors:  Andrew C Tiu; Jian Yang; Laureano D Asico; Prasad Konkalmatt; Xiaoxu Zheng; Santiago Cuevas; Xiaoyan Wang; Hewang Lee; Momina Mazhar; Robin A Felder; Pedro A Jose; Van Anthony M Villar
Journal:  FASEB J       Date:  2020-04-07       Impact factor: 5.191

5.  Sphingolipids and Redox Signaling in Renal Regulation and Chronic Kidney Diseases.

Authors:  Owais M Bhat; Xinxu Yuan; Guangbi Li; RaMi Lee; Pin-Lan Li
Journal:  Antioxid Redox Signal       Date:  2018-01-09       Impact factor: 8.401

6.  Proinflammatory actions of visfatin/nicotinamide phosphoribosyltransferase (Nampt) involve regulation of insulin signaling pathway and Nampt enzymatic activity.

Authors:  Claire Jacques; Martin Holzenberger; Zvezdana Mladenovic; Colette Salvat; Emilie Pecchi; Francis Berenbaum; Marjolaine Gosset
Journal:  J Biol Chem       Date:  2012-03-07       Impact factor: 5.157

Review 7.  Inflammasome Activation in Chronic Glomerular Diseases.

Authors:  Sabena M Conley; Justine M Abais; Krishna M Boini; Pin-Lan Li
Journal:  Curr Drug Targets       Date:  2017       Impact factor: 3.465

8.  Reversal by growth hormone of homocysteine-induced epithelial-to-mesenchymal transition through membrane raft-redox signaling in podocytes.

Authors:  Cai-Xia Li; Min Xia; Wei-Qing Han; Xiao-Xue Li; Chun Zhang; Krishna M Boini; Xiao-Cheng Liu; Pin-Lan Li
Journal:  Cell Physiol Biochem       Date:  2011-06-17

9.  Acid sphingomyelinase gene deficiency ameliorates the hyperhomocysteinemia-induced glomerular injury in mice.

Authors:  Krishna M Boini; Min Xia; Caixia Li; Chun Zhang; Lori P Payne; Justine M Abais; Justin L Poklis; Philip B Hylemon; Pin-Lan Li
Journal:  Am J Pathol       Date:  2011-09-03       Impact factor: 4.307

10.  Podocyte NLRP3 Inflammasome Activation and Formation by Adipokine Visfatin.

Authors:  Saisudha Koka; Min Xia; Chun Zhang; Yang Zhang; Pin-Lan Li; Krishna M Boini
Journal:  Cell Physiol Biochem       Date:  2019
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.